Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 20 November 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

c-Myc overexpression associated with cancer in Barrett's

c-Myc overexpression is strongly associated with the metaplasia-dysplasia-adenocarcinoma sequence in the esophagus, reports the latest Diseases of the Esophagus.

News image

fiogf49gjkf04

Barrett's esophagus develops as a result of a severe esophageal mucosa injury from gastroesophageal reflux.

Barrett's esophagus is a premalignant lesion and plays an important role in the development of esophageal adenocarcinoma.

Dr Schmidt and colleagues from Brazil determined the expression of the proto-oncogene c-Myc in patients with Barrett's esophagus, and esophageal adenocarcinoma.

The research team evaluated the prevalence of such expression in relation to the metaplasia-dysplasia-adenocarcinoma sequence.

c-Myc overexpression occurred in 37% of Barrett's esophagus
Diseases of the Esophagus

The team identified several genetic alterations in the process that transforms a normal cell into a tumorous one.

In the development of human tumors, one of the most important genes is the proto-oncogene c-Myc.

The researchers then determined c-Myc protein expression by immunohistochemical analysis in 4 different groups.

The team reported that there were 31 patients with normal tissue, and 43 patients with Barrett's esophagus without dysphasia.

The team also identified 11 patients with dysplasia in Barrett's esophagus, and 37 patients with esophageal adenocarcinoma.

The material was obtained from esophageal biopsies or the dissection of patient esophagectomy specimens.

The researchers analyzed demographic and endoscopic data that included sex, age, race and intestinal metaplasia extension.

In addition the team assessed morphologic and histopathologic tumor characteristics.

The research team evaluated deep tumor invasion, lymph node status, and tumor differentiation.

The c-Myc expression was assessed using the Immunoreactive Scoring System.

The team found overexpression of c-Myc in only 10% of normal tissue specimens.

c-Myc overexpression occurred in 37% of Barrett's esophagus patients, and 46% of Barrett's esophagus patients with dysphasia.

In adenocarcinoma samples, the team observed c-Myc over expression in 73%.

There was no significant statistical difference among these groups.

The research team identified no correlation when the c-Myc expression was compared with morphologic and histologic tumor features or endoscopic data.

However, linear correlation of c-Myc overexpression along the metaplasia-dysplasia-adenocarcinoma sequence was observed.

Dr Schmidt's team concluded, "This study demonstrates a significant increase in the expression of c-Myc in Barrett's esophagus dysplasia and adenocarcinoma in relation to the control group.

"We also found a linear progression of this gene expression in this sequence."

"These results point out the importance of this marker in the development of esophageal adenocarcinoma from Barrett's esophagus."

Dis Esophagus 2007:20(3): 212-6
24 May 2007

Go to top of page Email this page Email this page to a colleague

 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Predicting microscopic colitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD
 15 November 2017 
Medication nonadherence and health care costs
 15 November 2017 
Predicting recurrence after curative rectal cancer surgery
 14 November 2017 
HBV/HCV coinfection and cirrhosis
 14 November 2017 
Sexual dysfunction after rectal cancer surgery
 14 November 2017 
Eosinophilic gastroenteritis and colitis
 13 November 2017 
GI bleeding in patients taking non–vitamin K antagonist oral anticoagulants
 13 November 2017 
Genetic polymorphisms, fatty acids and ulcerative colitis
 13 November 2017 
Flares after immunomodulator withdrawal in Crohn's
 10 November 2017 
Thiopurines vs TNF and lymphoma risk in IBD
 10 November 2017 
Drug monitoring of anti-tumour necrosis factor therapy in IBD
 10 November 2017 
Treatment decisions for older patients with colorectal cancer
 09 November 2017 
Quality standards in upper gastrointestinal endoscopy
 09 November 2017 
Irradiated rectal cancer and chemoradiotherapy
 09 November 2017 
Environmental factors and IBD
 08 November 2017 
Prophylaxis of spontaneous bacterial peritonitis
 08 November 2017 
Optimal management of postoperative Crohn's disease
 07 November 2017 
Community Screening for Helicobacter pylori
 07 November 2017 
Early readmission in IBD patients
 07 November 2017 
Mesocolic excision for colon cancer
 06 November 2017 
Food elimination diet for children with eosinophilic esophagitis
 06 November 2017 
Biologic agents and obesity in children with IBD
 06 November 2017 
Liver cancer burden despite extensive use of antiviral agents
 03 November 2017 
Statins and mortality in chronic viral hepatitis
 03 November 2017 
Propofol for outpatient colonoscopy
 03 November 2017 
Asthma and IBD development
 02 November 2017 
Diverticulitis and emergency department burden
 02 November 2017 
Rural residence and risk of IBD
 02 November 2017 
Sexual functioning in Hep C
 01 November 2017 
Heartburn relief in adolescents with GERD
 01 November 2017 
Autoimmune pancreatitis in children
 31 October 2017 
Follow-up of positive results on fecal blood tests
 31 October 2017 
Surveillance in ulcerative colitis and Crohn’s disease
 30 October 2017 
Local recurrence after curative rectal cancer surgery
 30 October 2017 
Low-flow ascites pump in refractory cirrhosis
 30 October 2017 
Medical therapy of patients with pediatric-onset IBD
 27 October 2017 
NAFLD in advanced fibrosis in the USA
 27 October 2017 
Early readmission in cirrhosis after bacterial infections
 26 October 2017 
Predicting response to anti-TNF therapy in Crohn's
 26 October 2017 
Conversion to open laparotomy in rectal cancer
 25 October 2017 
Conversion of colonoscopy to sigmoidoscopy
 25 October 2017 
Fecal microbiota transplantation
 25 October 2017 
Rifaximin and survival in hepatic encephalopathy
 24 October 2017 
Eosinophilic esophagitis with swallowed topical corticosteroids
 24 October 2017 
Meta-analysis in nutritiona research
 23 October 2017 
NAFLD-related hepatocellular carcinoma in liver resection
 23 October 2017 
Outcome of hepatic sarcoidosis
 20 October 2017 
Conversion of planned colonoscopy to sigmoidoscopy
 20 October 2017 
Hospital readmissions reduction program
 19 October 2017 
Surgical anastomosis at 1-year colorectal cancer surveillance
 19 October 2017 
Fecal immunochemical tests in colorectal cancer screening

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us